125 related articles for article (PubMed ID: 8105839)
1. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
[TBL] [Abstract][Full Text] [Related]
2. DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer.
Medl M; Sevelda P; Czerwenka K; Dobianer K; Hanak H; Hruza C; Klein M; Leodolter S; Müllauer-Ertl S; Rosen A
Gynecol Oncol; 1995 Dec; 59(3):321-6. PubMed ID: 8522248
[TBL] [Abstract][Full Text] [Related]
3. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
[TBL] [Abstract][Full Text] [Related]
4. First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer.
Rosen A; Sevelda P; Klein M; Dobianer K; Hruza C; Czerwenka K; Hanak H; Vavra N; Salzer H; Leodolter S
Br J Cancer; 1993 May; 67(5):1122-5. PubMed ID: 8494710
[TBL] [Abstract][Full Text] [Related]
5. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
Friedrichs K; Lohmann D; Höfler H
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
[TBL] [Abstract][Full Text] [Related]
6. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
7. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction.
Sestini R; Orlando C; Zentilin L; Gelmini S; Pinzani P; Bianchi S; Selli C; Giacca M; Pazzagli M
Clin Chem; 1994 Apr; 40(4):630-6. PubMed ID: 7511998
[TBL] [Abstract][Full Text] [Related]
8. Gene amplification for c-erbB-2, c-myc, epidermal growth factor receptor, int-2, and N-myc measured by quantitative PCR with a multiple competitor template.
Sestini R; Orlando C; Zentilin L; Lami D; Gelmini S; Pinzani P; Giacca M; Pazzagli M
Clin Chem; 1995 Jun; 41(6 Pt 1):826-32. PubMed ID: 7768000
[TBL] [Abstract][Full Text] [Related]
9. HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors.
Dobianer K; Hruza C; Ehrlich G; Sevelda P; Czerwenka K; Soreq H; Spona J; Zakut H
Gynecol Oncol; 1995 Feb; 56(2):200-6. PubMed ID: 7896186
[TBL] [Abstract][Full Text] [Related]
10. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.
Seki A; Yoshinouchi M; Seki N; Kodama J; Miyagi Y; Kudo T
Int J Oncol; 2000 Jul; 17(1):103-6. PubMed ID: 10853025
[TBL] [Abstract][Full Text] [Related]
11. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
[TBL] [Abstract][Full Text] [Related]
12. Multiple genetic lesions in laryngeal squamous cell carcinomas.
Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
[TBL] [Abstract][Full Text] [Related]
13. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral heterogeneity for amplified genes in human breast carcinoma.
Lönn U; Lönn S; Nilsson B; Stenkvist B
Int J Cancer; 1994 Jul; 58(1):40-5. PubMed ID: 7912234
[TBL] [Abstract][Full Text] [Related]
15. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
[TBL] [Abstract][Full Text] [Related]
16. A paradigm for oncogene complementation in human breast cancer.
Roux-Dosseto M; Martin PM
Res Virol; 1989; 140(6):571-91. PubMed ID: 2694252
[TBL] [Abstract][Full Text] [Related]
17. Sequence analysis of the int-2/fgf-3 gene in aggressive human breast carcinomas.
Meyers SL; Dudley JP
Mol Carcinog; 1992; 6(4):243-51. PubMed ID: 1362493
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification of int-2 and erbB in human esophageal cancer: relationship to clinicopathological variables.
Suzuki H; Abo S; Kitamura M; Hashimoto M; Izumi K; Terada K; Sugiyama T
Cancer Invest; 1997; 15(5):411-5. PubMed ID: 9316622
[TBL] [Abstract][Full Text] [Related]
19. Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue.
Hunter SB; Abbott K; Varma VA; Olson JJ; Barnett DW; James CD
J Neuropathol Exp Neurol; 1995 Jan; 54(1):57-64. PubMed ID: 7815080
[TBL] [Abstract][Full Text] [Related]
20. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
[Next] [New Search]
